![]() |
|
|
|
|
|||||||
|
|
|
2006-09-26 News Release
Achieving CGMP for pharmaceutical intermediates A leading service provider of custom manufacturing, emphasizes its commitment to exclusive synthesis of innovative pharmaceutical intermediates and active ingredients.
By achieving CGMP (Current Good Manufacturing Practice) status for a
high-pressure hydrogenation production facility, Saltigo GmbH, a leading
service provider for custom synthesis and custom manufacturing, is once
again emphasizing its commitment to exclusive synthesis of innovative
pharmaceutical intermediates and active ingredients. To this end, the
wholly owned subsidiary of the LANXESS chemicals group offers its customers
throughout the world market-focused and customer-oriented complete solutions
for the development, piloting and production of active ingredients and
intermediates.
“The plant enables us to carry out practically any typical hydrogenation reaction and a wide range of special reactions,” comments Dr. Claus Dreisbach, hydrogenation plant manager at Saltigo. These reactions range from hydrogenation of aromatic nitro compounds and nuclear hydrogenation of aromatics to reduction of aldehydes, ketones, imines, nitriles and compounds with carbon-carbon multiple bonds, and reductive aminations and alkylations. An extremely wide range of catalysts can be used for these applications. Typical heterogeneous catalysts (e.g. Raney metals or carrier-fixed platinum metals) can be used, as can homogeneous catalysts, for example combinations of ruthenium compounds and chiral bisphosphane ligands for homogeneous enantioselective hydrogenation. Saltigo’s extensive expertise in high-pressure hydrogenation on a production scale is further enhanced by the synthetic opportunities that the ZeTO* (Central Organics Pilot Plant) offers specifically for piloting and production under CGMP conditions. There is also the capacity for small-scale high-pressure hydrogenation in liter volumes. Furthermore, Saltigo Alongside a diverse range of basic CGMP technologies and the above-mentioned
high-pressure hydrogenation under CGMP conditions, Saltigo also offers
customers special reactions in regulated areas of application (e.g. phosgenations
and fluorinations) and the ability to handle reagents with a high energy
content and highly exothermic reactions safely and reliably. This technology
portfolio enables Saltigo to rapidly develop cutting-edge solutions to
meet the demands of customers in the pharmaceutical industry.
Click here to view more news headlines.
|
Maybe
it's time to check your Homeowners![]() News / Resources - Chemicals activities represent landmark - Certification, Training and Courses from The American Management Association - Small quantities Fast - Plastics, Metals, Tool Steel and ... - Looking for a Study Program? - All this Months News - Changing Jobs? View Homes for Sale in the U.S. - Buy Golf Equipment Direct from the Manufacturer and Save! Copyright
- Unless otherwise
stated all contents of this web site are © 1998/2006 JOBWERX.COM.
– All Rights Reserved. For permission to reproduce any contents of this
web site, please advise our Syndication department: Log onto HELP
|
|
|